Sign in Subscribe

Wells Fargo Initiates Coverage of Pyxis Oncology with $12 Target, Sees Shares Doubling on Fall Update

Dose cap de-risks MICVO as Wells Fargo starts Pyxis at Overweight with $12 target. Sees at least 2x upside on fall HNSCC update.

Wells Fargo Initiates Coverage of Pyxis Oncology with $12 Target, Sees Shares Doubling on Fall Update
Credit: Pyxis Oncology
Already have an account? Sign in.